Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 1, 1999, Pages 131-136

  Aquilina, Joseph ^b   Barnett, Adrian ^b   Thompson, Olaleye ^b   Harrington, Kevin ^a  

^a HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Inhibin; Preeclampsia; Screening

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRADIOL; INHIBIN A;

ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NEWBORN DEATH; PREECLAMPSIA; PREGNANCY COMPLICATION; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE; STILLBIRTH; TRISOMY 21;

EID: 0012690591     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70448-5     Document Type: Article

References (23)

1. 1. Report on confidential enquiries into maternal deaths in the United Kingdom 1994-1996. London: Her Majesty's Stationery Office; 1997.
2. 2. Eskenazi B, Feuster L, Sidney S, Elkin EP. Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. Am J Obstet Gynecol 1993;169:1112-6.
3. 3. Meekins JW, Pijnenborg R, Hausseus M, McFayden IR, Van Asshe A. A study of placental bed spiral arteries and trophoblastic invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynecol 1994;101:669-74.
4. 4. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;338:701-5.
5. 5. Sibai BM, Caritis SN, Throm E, Klebanoff M, McNellis D, Rocco L, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1993;329:1213-8.
6. 6. Conde-Agudelo A, Lede R, Belizan J. Evaluation of methods used in the prediction of hypertensive disorders of pregnancy. Obstet Gynecol Surv 1994;49:210-22.
7. 7. Messague J. The transforming growth factor beta family. Ann Rev Cell Biol 1990;6:597-641.
8. 8. Illingworth PJ, Reddi K, Wickings EJ, Baird DT. The source of inhibin secretion during the human menstrual cycle. J Clin Endocrinol Metabol 1991;73:667-73.
9. 9. Qu J, Thomas K. Inhibin and activin production in the human placenta. Endocr Rev 1995;16:485-507.
10. 10. Illingworth PJ, Groome NP, Duncan WC, Grant V, Tovanabutra S, Baird DT, et al. Measurement of circulating inhibin forms during establishment of pregnancy. J Clin Endocrinol Metabol 1996;81:1471-5.
11. 11. Muttukrishna S, George L, Fowler PA, Groome NP, Knight PG. Measurement of serum concentrations of inhibin-A (α-βA dimer) during human pregnancy. Clin Endocrinol 1995;2:391-7.
12. 12. Healy DL, Polson D, Yohkachiya T, de Kretser DM. Inhibin and related peptides in pregnancy. Baillieres Clin Endocrinol Metab 1990;4:233-47.
13. 13. Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 1996;16:143-5.
14. 14. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, et al. Maternal serum screening for Down's syndrome in early pregnancy [published erratum appears in BMJ 1988;297:1029]. BMJ 1988;297:883-7.
15. 15. Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL. Activin-A and inhibin-A as possible endocrine markers for pre-eclampsia. Lancet 1997;349:1285-8.
16. 16. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:892-8.
17. 17. Yudkin PL, Aboualfa M, Eyre JA, Redman CW, Wilkinson AR. New birth weight and heart circumference centiles for gestational ages 24-42 weeks. Early Hum Dev 1987;15:45-52.
18. 18. Roberts JM, Redman CW. Pre-eclampsia; more than just pregnancy-induced hypertension. Lancet 1993;341:1447-51.
19. 19. Arnholdt H, Meisel F, Fandrey K, Löhrs U. Proliferation of villous trophoblast of the human placenta in human placenta in normal and abnormal pregnancies. Virchows Arch B Cell Pathol Incl Mol Pathol 1991;60:365-72.
20. 20. McCluggage WG, Ashe P, McBride H, Maxwell T, Sloan JM. Localization of the cellular expression of inhibin in trophoblastic tissue. Histopathology 1998;32:252-6.
21. 21. Muller F, Savey L, Le Fibler F, Bussieres L, Nyadizimba G, Colau JC, Giraudet P. Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for preeclampsia. Am J Obstet Gynecol 1996;175:37-40.
22. 22. Petraglia F, Sawchenko P, Lim AT, Rivier J, Vale W. Localization, secretion, and action of inhibin in human placenta. Science 1987;237:187-9.
23. 23. Harrington K, Carpenter RG, Goldfrad C, Campbell S. Transvaginal Doppler ultrasound of the uteroplacental circulation in the early prediction of pre-eclampsia and intrauterine growth retardation. Br J Obstet Gynaecol 1997;104:674-81.